Atomic AI is developing RNA-centric medicines using a platform that fuses machine learning and structural biology. Their core product, the ATOM-1 foundation model, enables precise predictions of RNA 3D structure to unlock new therapeutic targets. They serve the field of drug discovery, focusing on RNA-targeted small molecules and RNA-based therapeutics.